Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS
· Delayed Price · Currency is USD
8.71
-0.47 (-5.12%)
Mar 28, 2025, 4:00 PM EST
Cipher Pharmaceuticals Revenue
In the year 2024, Cipher Pharmaceuticals had annual revenue of $33.36M with 57.66% growth. Cipher Pharmaceuticals had revenue of $11.82M in the quarter ending December 31, 2024, with 140.28% growth.
Revenue
33.36M
Revenue Growth
+57.66%
P/S Ratio
n/a
Revenue / Employee
6.67M
Employees
5
Market Cap
225.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.36M | 12.20M | 57.66% |
| Dec 31, 2023 | 21.16M | 487.00K | 2.36% |
| Dec 31, 2022 | 20.68M | -1.27M | -5.78% |
| Dec 31, 2021 | 21.94M | 336.00K | 1.56% |
| Dec 31, 2020 | 21.61M | -844.00K | -3.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| SS Innovations International | 16.04M |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| American Oncology Network | 1.76B |
Cipher Pharmaceuticals News
- 3 days ago - Cannabis Stock Gainers And Losers From March 27, 2025 - Benzinga
- 11 days ago - Cipher Pharmaceuticals Inc (CPHRF) Q4 2024 Earnings Call Highlights: Record Revenue Surge and ... - GuruFocus
- 11 days ago - Marijuana Stock Movers For March 19, 2025 - Benzinga
- 12 days ago - Cipher Pharmaceuticals GAAP EPS of $0.13, revenue of $11.82M misses by $0.28M - Seeking Alpha
- 12 days ago - Cipher Pharmaceuticals Inc. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Cipher Pharmaceuticals Inc. (CPHRF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Cipher Pharmaceuticals GAAP EPS of $0.13 misses by $0.02, revenue of $11.82M misses by $0.43M - Seeking Alpha
- 2 months ago - Jesse Gamble's Top Picks: Zedcor, Enterprise Group and Cipher Pharmaceuticals - BNN Bloomberg